Genetic modifiers ameliorate endocytic and neuromuscular defects in a model of spinal muscular atrophy.
Melissa B WalshEva JanzenEmily WingroveSeyyedmohsen HosseinibarkooieNatalia Rodriguez MuelaLance DavidowMaria DimitriadiErika M NorabuenaLee L RubinBrunhilde WirthAnne C HartPublished in: BMC biology (2020)
We propose that hnRNP F/H act in the same protein complex as PLS3 and SMN and that the function of this complex is critical for endocytic pathways, suggesting that hnRNP F/H proteins could be potential targets for therapy development.